Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia flag Australia · Delayed Price · Currency is AUD
11.68
-0.07 (-0.60%)
Mar 28, 2025, 4:10 PM AEST

Clinuvel Pharmaceuticals Revenue

Clinuvel Pharmaceuticals had revenue of 35.65M AUD in the half year ending December 31, 2024, with 21.39% growth. This brings the company's revenue in the last twelve months to 91.02M, up 11.34% year-over-year. In the fiscal year ending June 30, 2024, Clinuvel Pharmaceuticals had annual revenue of 88.18M with 12.59% growth.

Revenue (ttm)
91.02M
Revenue Growth
+11.34%
P/S Ratio
6.43
Revenue / Employee
5.69M
Employees
16
Market Cap
583.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202488.18M9.86M12.59%
Jun 30, 202378.32M12.60M19.17%
Jun 30, 202265.72M17.40M36.02%
Jun 30, 202148.32M15.75M48.37%
Jun 30, 202032.57M1.52M4.89%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Mesoblast 9.16M
Revenue Rankings